Literature DB >> 26202926

Tumor-associated macrophages and extracellular matrix metalloproteinase inducer in prognosis of multiple myeloma.

S Panchabhai1, K Kelemen2, G Ahmann1, S Sebastian1, J Mantei1, R Fonseca1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26202926     DOI： 10.1038/leu.2015.191

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  16 in total

Review 1.  Macrophages in multiple myeloma: emerging concepts and therapeutic implications.

Authors:  Fotis Asimakopoulos; Jaehyup Kim; Ryan A Denu; Chelsea Hope; Jeffrey L Jensen; Samuel J Ollar; Ellen Hebron; Claire Flanagan; Natalie Callander; Peiman Hematti
Journal:  Leuk Lymphoma       Date:  2013-04-11

Review 2.  Repertoire of microglial and macrophage responses after spinal cord injury.

Authors:  Samuel David; Antje Kroner
Journal:  Nat Rev Neurosci       Date:  2011-06-15       Impact factor: 34.870

3.  Interleukin-10 Induces Both Plasma Cell Proliferation and Angiogenesis in Multiple Myeloma.

Authors:  Michael G Alexandrakis; Nektaria Goulidaki; Constantina A Pappa; Anna Boula; Fotios Psarakis; Ioannis Neonakis; George Tsirakis
Journal:  Pathol Oncol Res       Date:  2015-03-06       Impact factor: 3.201

Review 4.  Microenvironment and multiple myeloma spread.

Authors:  Domenico Ribatti; Michele Moschetta; Angelo Vacca
Journal:  Thromb Res       Date:  2014-05       Impact factor: 3.944

5.  Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.

Authors:  Morten N Andersen; Niels Abildgaard; Maciej B Maniecki; Holger J Møller; Niels F Andersen
Journal:  Eur J Haematol       Date:  2014-03-20       Impact factor: 2.997

6.  Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases.

Authors:  Yi Tang; Marian T Nakada; Prabakaran Kesavan; Francis McCabe; Hillary Millar; Patricia Rafferty; Peter Bugelski; Li Yan
Journal:  Cancer Res       Date:  2005-04-15       Impact factor: 12.701

7.  Increased expression of extracellular matrix metalloproteinase inducer (CD147) in multiple myeloma: role in regulation of myeloma cell proliferation.

Authors:  B K Arendt; D K Walters; X Wu; R C Tschumper; P M Huddleston; K J Henderson; A Dispenzieri; D F Jelinek
Journal:  Leukemia       Date:  2012-03-30       Impact factor: 11.528

8.  Interleukin-10 is a growth factor for human myeloma cells by induction of an oncostatin M autocrine loop.

Authors:  Z J Gu; V Costes; Z Y Lu; X G Zhang; V Pitard; J F Moreau; R Bataille; J Wijdenes; J F Rossi; B Klein
Journal:  Blood       Date:  1996-11-15       Impact factor: 22.113

9.  Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma.

Authors:  C Scavelli; B Nico; T Cirulli; R Ria; G Di Pietro; D Mangieri; A Bacigalupo; G Mangialardi; A M L Coluccia; T Caravita; S Molica; D Ribatti; F Dammacco; A Vacca
Journal:  Oncogene       Date:  2007-07-30       Impact factor: 9.867

10.  Multiple myeloma macrophages: pivotal players in the tumor microenvironment.

Authors:  Simona Berardi; Roberto Ria; Antonia Reale; Annunziata De Luisi; Ivana Catacchio; Michele Moschetta; Angelo Vacca
Journal:  J Oncol       Date:  2013-01-30       Impact factor: 4.375
View more
  23 in total

Review 1.  Macrophages in multiple myeloma: key roles and therapeutic strategies.

Authors:  Khatora S Opperman; Kate Vandyke; Peter J Psaltis; Jacqueline E Noll; Andrew C W Zannettino
Journal:  Cancer Metastasis Rev       Date:  2021-01-06       Impact factor: 9.264

2.  CyBorD-DARA is potent initial induction for MM and enhances ADCP: initial results of the 16-BCNI-001/CTRIAL-IE 16-02 study.

Authors:  M O'Dwyer; R Henderson; S D Naicker; M R Cahill; P Murphy; V Mykytiv; J Quinn; C McEllistrim; J Krawczyk; J Walsh; E Lenihan; T Kenny; A Hernando; G Hirakata; I Parker; E Kinsella; G Gannon; A Natoni; K Lynch; A E Ryan
Journal:  Blood Adv       Date:  2019-06-25

Review 3.  Metabolic Syndrome after Hematopoietic Cell Transplantation: At the Intersection of Treatment Toxicity and Immune Dysfunction.

Authors:  Lucie M Turcotte; Ashley Yingst; Michael R Verneris
Journal:  Biol Blood Marrow Transplant       Date:  2016-03-22       Impact factor: 5.742

Review 4.  Metabolic underpinnings of leukemia pathology and treatment.

Authors:  Travis Nemkov; Angelo D'Alessandro; Julie A Reisz
Journal:  Cancer Rep (Hoboken)       Date:  2018-10-07

Review 5.  Extracellular matrix and the myeloid-in-myeloma compartment: balancing tolerogenic and immunogenic inflammation in the myeloma niche.

Authors:  Fotis Asimakopoulos; Chelsea Hope; Michael G Johnson; Adam Pagenkopf; Kimberly Gromek; Bradley Nagel
Journal:  J Leukoc Biol       Date:  2017-03-02       Impact factor: 4.962

6.  PKM2 and other key regulators of Warburg effect positively correlate with CD147 (EMMPRIN) gene expression and predict survival in multiple myeloma.

Authors:  S Panchabhai; I Schlam; S Sebastian; R Fonseca
Journal:  Leukemia       Date:  2016-12-27       Impact factor: 11.528

7.  Aqueous Extract of Cimicifuga dahurica Reprogramming Macrophage Polarization by Activating TLR4-NF-κB Signaling Pathway.

Authors:  Shushu Qian; Xuan Han; Xiaocao Sha; Fang Tian; Hong Huang; Pengjun Jiang; Guoshun Huang; Bangyun Ma; Hong Zhang; Yiye Zhu; Xuemei Sun
Journal:  J Inflamm Res       Date:  2022-02-15

8.  BMI1 regulates multiple myeloma-associated macrophage's pro-myeloma functions.

Authors:  Danfeng Zhang; Jingcao Huang; Fangfang Wang; Hong Ding; Yushan Cui; Yan Yang; Juan Xu; Hongmei Luo; Yuhan Gao; Ling Pan; Yu Wu; Yuping Gong; Liping Xie; Zhigang Liu; Ying Qu; Li Zhang; Weiping Liu; Wenyan Zhang; Sha Zhao; Qing Yi; Ting Niu; Yuhuan Zheng
Journal:  Cell Death Dis       Date:  2021-05-15       Impact factor: 8.469

9.  CD4+ T-cell killing of multiple myeloma cells is mediated by resident bone marrow macrophages.

Authors:  Ole Audun W Haabeth; Kjartan Hennig; Marte Fauskanger; Geir Åge Løset; Bjarne Bogen; Anders Tveita
Journal:  Blood Adv       Date:  2020-06-23

Review 10.  Mechanisms of Immune Evasion in Multiple Myeloma: Open Questions and Therapeutic Opportunities.

Authors:  Cirino Botta; Francesco Mendicino; Enrica Antonia Martino; Ernesto Vigna; Domenica Ronchetti; Pierpaolo Correale; Fortunato Morabito; Antonino Neri; Massimo Gentile
Journal:  Cancers (Basel)       Date:  2021-06-28       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.